MétaCan
Menu
Back to cohort
Record W4395697371 · doi:10.1016/j.adro.2024.101528

Concurrent Olaparib and Radiation Therapy for BRCA2-Mutated Breast Cancer

2024· article· en· W4395697371 on OpenAlexaff
Danny Lavigne, Lucas Sidéris, Lara De Guerké, Eve‐Lyne Marchand, Suzanne Fortin, Pierre Dubé, Peter Vavassis, Marie-Hélène Auclair, Michael Yassa

Bibliographic record

VenueAdvances in Radiation Oncology · 2024
Typearticle
Languageen
FieldMedicine
TopicPARP inhibition in cancer therapy
Canadian institutionsUniversité de MontréalHôpital Maisonneuve-Rosemont
Fundersnot available
KeywordsOlaparibMedicineBreast cancerRadiation therapyOncologyAxillaInternal medicinePopulationOvarian cancerCancer

Abstract

fetched live from OpenAlex

Data regarding the safety of concurrent olaparib and radiation therapy in patients with BRCA1/2-mutated breast cancer are very limited. We report the case of a 45-year-old woman treated with concurrent adjuvant olaparib and radiation therapy for a recurrent BRCA2-mutated breast cancer presenting with a synchronous advanced-stage ovarian cancer. The patient received standard-dose locoregional radiation therapy to the ipsilateral breast, axilla, supraclavicular region, and internal mammary chain, with concurrent reduced-dose olaparib. The treatment was well tolerated with no unexpected acute toxicity. Further clinical trials are needed to confirm the safety and efficacy of concurrent olaparib and radiation therapy in this patient population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.983
Threshold uncertainty score0.547

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.415
Teacher spread0.395 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAdvances in Radiation OncologySame topicPARP inhibition in cancer therapyFrench-language works237,207